SV Tech Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Seed, Series A, Series B
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Singapore, China, India, Brazil, France, Mexico, Indonesia, South Korea, South Africa, Vietnam, Malaysia, New Zealand, Philippines, Thailand
Industries Focus
- Technology
- Healthcare
- Consumer Goods
- Telecommunications
- Media
- Software
- FinTech
- E-commerce
- Artificial Intelligence
- Pharmaceuticals
- Medical Devices
- Semiconductors
- Machine Learning
- Biotechnology
- Clean Energy
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2015
SV Tech Ventures is a venture capital firm based in Palo Alto, California, specializing in early-stage investments in technology companies worldwide. The firm focuses on startups that develop advanced technologies with high barriers to entry and significant market potential. Their portfolio spans various sectors, including healthcare, consumer goods, biotechnology, medical devices, pharmaceuticals, software, artificial intelligence, machine learning, fintech, e-commerce, media, telecommunications, semiconductors, and clean energy.
The firm's investment strategy encompasses multiple stages, from seed funding to Series B rounds, with investment sizes ranging from $1 million to $50 million. SV Tech Ventures has a global geographical focus, with investments in regions such as the United States, China, India, Indonesia, Singapore, Malaysia, Vietnam, Thailand, the Philippines, South Korea, Japan, Australia, New Zealand, the United Kingdom, Germany, France, Canada, Brazil, Mexico, and South Africa.
SV Tech Ventures has a track record of successful exits, including the acquisition of Original Stitch Inc. by World Co., the acquisition of NeuroVasc by an undisclosed acquirer, and the public listing of Turning Point Therapeutics on Nasdaq. The firm's philosophy centers on partnering with companies that demonstrate the capability to develop advanced technologies, particularly those protected by high barriers to entry, thereby achieving market leadership positions and making significant impacts on industries and society.
Requirements
- Advanced technology development
- High barriers to entry
- Significant market potential
- Strong management team
- Scalable business model
- Innovative product or service
- Clear path to profitability
- Ability to achieve market leadership
- Potential for significant industry impact
- Alignment with SV Tech Ventures' investment strategy
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- This is L
- Original Stitch Inc.
- NeuroVasc
- Turning Point Therapeutics
- Arrinex
- Neuvector
- Oculli
- Apexgen
Mentioned In
-
$24.95
-
$9.95
-
$49.95
-
$9.95
-
$9.95
-
$19.95
-
$14.95
-
$19.95
-
$39.95
-
$19.95
-
$24.95
-
$99.00
-
$195.00
-
$299.00
Claim this Investor
Are you an official representative of SV Tech Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim